{"id":61098,"date":"2025-04-16T01:05:08","date_gmt":"2025-04-15T23:05:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/"},"modified":"2025-04-16T01:05:08","modified_gmt":"2025-04-15T23:05:08","slug":"aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/","title":{"rendered":"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b><i>Places in top 1% of EcoVadis\u2019 rankings for all industries<\/i><\/b>\n<\/p>\n<p>CRYSTAL LAKE, Ill.&#8211;(BUSINESS WIRE)&#8211;AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among the top 1% of the more than 150,000 companies rated by EcoVadis across all industries.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/5\/csr.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/5\/csr.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/21\/csr.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/685330\/4\/aptar_logo_rgb.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/685330\/22\/aptar_logo_rgb.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/685330\/4\/aptar_logo_rgb.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/685330\/21\/aptar_logo_rgb.jpg\"><\/a><\/p>\n<p>\n&#8220;Aptar is honored to once again achieve the EcoVadis Platinum rating, a testament to our global commitment to sustainability,&#8221; explained Stephan B. Tanda, President and CEO. &#8220;Our innovative approach to eco-efficient operations, renewable energy and more sustainable products not only sets us apart but also enables us to support the world\u2019s leading brands with their goals. We are proud to be an industry leader in sustainability.&#8221;\n<\/p>\n<p>\nEcoVadis is a global standard for business sustainability ratings and its methodology is aligned to several established international frameworks and sustainability regulatory requirements. The EcoVadis Sustainability Scorecard illustrates company performance across four key themes: environment, labor and human rights, ethics and sustainable procurement.\n<\/p>\n<p>\nIn addition, collaborating with responsible suppliers helps Aptar achieve sustainable outcomes. By working with EcoVadis for its Supplier Screening Program, Aptar integrates social and environmental screenings into its purchasing process, enhancing risk understanding, transparency, and continuous improvement with suppliers.\n<\/p>\n<p>\nBeth Holland, Aptar\u2019s Chief Sustainability Officer, shared, \u201cMany of our customers view an EcoVadis ranking as a crucial factor for business partnerships and recognize the need for collaboration with companies that prioritize a comprehensive sustainability approach. We are honored to be recognized by EcoVadis for our continuous sustainability advancements and the steadfast dedication of our global teams to protect our planet and work towards a more sustainable future.\u201d\n<\/p>\n<p>\nAptar\u2019s focus on sustainability is reflected in our core values as a company but also as our commitment to being a responsible, inclusive global corporate citizen. Aptar is also an active member of the United Nations Global Compact, the Ellen MacArthur Foundation and the World Business Council for Sustainable Development. Aptar was also recently recognized with prestigious <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Faptar.com%2Fnews-events%2Faptar-recognized-with-prestigious-a-score-on-the-cdp-climate-change-assessment-2%2F&amp;esheet=54238472&amp;newsitemid=20250415248822&amp;lan=en-US&amp;anchor=%26%238216%3BA%26%238217%3B+score+on+the+CDP+Climate+Change+assessment&amp;index=1&amp;md5=ff44aee85d0850772793c62dd2e20624\" rel=\"nofollow\" shape=\"rect\">\u2018A\u2019 score on the CDP Climate Change assessment<\/a> and was named one of <i>Barron\u2019s <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Faptar.com%2Fnews-events%2Faptar-named-one-of-barrons-100-most-sustainable-u-s-companies-for-the-seventh-consecutive-year%2F&amp;esheet=54238472&amp;newsitemid=20250415248822&amp;lan=en-US&amp;anchor=100+Most+Sustainable+U.S.+Companies&amp;index=2&amp;md5=b43643b94b82c966528788e6fbc58032\" rel=\"nofollow\" shape=\"rect\">100 Most Sustainable U.S. Companies<\/a>.\n<\/p>\n<p>\nFor more information on Aptar\u2019s sustainability initiatives, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.aptar.com%2Fesg%2F&amp;esheet=54238472&amp;newsitemid=20250415248822&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.aptar.com%2Fesg%2F&amp;index=3&amp;md5=5dcdd40a84e5a2a903e3b0c5d5188e9d\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.aptar.com\/esg\/<\/a>.\n<\/p>\n<p>\n<b>About Aptar<\/b>\n<\/p>\n<p>\nAptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world\u2019s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aptar.com&amp;esheet=54238472&amp;newsitemid=20250415248822&amp;lan=en-US&amp;anchor=www.aptar.com&amp;index=4&amp;md5=5da398c648c1984b39161b63153a75f3\" rel=\"nofollow\" shape=\"rect\">www.aptar.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b><span class=\"bwuline\">Investor Relations Contact<\/span>:<\/b><br \/>Mary Skafidas<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#x3a;&#x6d;&#97;&#x72;y&#46;&#x73;k&#97;&#x66;&#105;&#x64;a&#115;&#x40;a&#112;&#x74;&#97;&#x72;&#x2e;&#99;&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#x6d;&#x61;&#x72;&#x79;&#x2e;&#x73;&#107;&#97;&#102;&#105;das&#64;&#x61;&#x70;&#x74;&#x61;&#x72;&#x2e;&#99;&#111;&#109;<\/a><br \/>815-479-5658\n<\/p>\n<p>\n<b><span class=\"bwuline\">Media Contact:<\/span><\/b><br \/>Katie Reardon<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;k&#x61;&#x74;&#105;e&#46;&#x72;&#101;&#97;r&#x64;&#x6f;&#110;&#64;&#x61;&#x70;&#116;&#97;r&#x2e;&#x63;&#111;m\" rel=\"nofollow\" shape=\"rect\">&#x6b;&#x61;&#x74;&#x69;&#101;&#46;rea&#x72;&#x64;&#x6f;&#x6e;&#64;&#97;pta&#x72;&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>815-479-5671\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Places in top 1% of EcoVadis\u2019 rankings for all industries CRYSTAL LAKE, Ill.&#8211;(BUSINESS WIRE)&#8211;AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61098","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Places in top 1% of EcoVadis\u2019 rankings for all industries CRYSTAL LAKE, Ill.&#8211;(BUSINESS WIRE)&#8211;AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T23:05:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year\",\"datePublished\":\"2025-04-15T23:05:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/\"},\"wordCount\":513,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250415248822\\\/en\\\/2439541\\\/22\\\/csr.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/\",\"name\":\"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250415248822\\\/en\\\/2439541\\\/22\\\/csr.jpg\",\"datePublished\":\"2025-04-15T23:05:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250415248822\\\/en\\\/2439541\\\/22\\\/csr.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250415248822\\\/en\\\/2439541\\\/22\\\/csr.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/","og_locale":"en_US","og_type":"article","og_title":"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Pharma Trend","og_description":"Places in top 1% of EcoVadis\u2019 rankings for all industries CRYSTAL LAKE, Ill.&#8211;(BUSINESS WIRE)&#8211;AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/","og_site_name":"Pharma Trend","article_published_time":"2025-04-15T23:05:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year","datePublished":"2025-04-15T23:05:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/"},"wordCount":513,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/","url":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/","name":"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg","datePublished":"2025-04-15T23:05:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250415248822\/en\/2439541\/22\/csr.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aptar-receives-platinum-rating-from-ecovadis-for-the-fifth-consecutive-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61098"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61098\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}